Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,985 public trials 746 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01350128

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Pearl Investigative Site Panama City, Florida, United States
  • Pearl Investigative Site Winter Park, Florida, United States
  • Pearl Investigative Site Cherry Hill, New Jersey, United States
  • Pearl Investigative Site Summit, New Jersey, United States
View Trial Details
Completed

Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

NCT01323673

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +12 more
Locations
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Boynton Beach, Florida, United States
  • GSK Investigational Site West Palm Beach, Florida, United States
  • GSK Investigational Site Louisville, Kentucky, United States
View Trial Details
Completed

Efficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT02196077

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Pearl Investigative Site Rolling Hills Estates, California, United States
  • Pearl Investigative Site Clearwater, Florida, United States
  • Pearl Investigative Site Panama City, Florida, United States
  • Pearl Investigative Site Tampa, Florida, United States
View all 17 locations
View Trial Details
Completed

Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma

NCT01687296

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +10 more
Locations
  • GSK Investigational Site Changsha, Hunan, China
  • GSK Investigational Site Yanji, Jilin, China
  • GSK Investigational Site Shenyang, Liaoning, China
  • GSK Investigational Site Wenzhou, Zhejiang, China
View Trial Details

Related conditions